Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.

Huss M, Chen W, Ludolph AG.

Clin Drug Investig. 2016 Jan;36(1):1-25. doi: 10.1007/s40261-015-0336-0. Review.

2.

Circadian modulation of dopamine levels and dopaminergic neuron development contributes to attention deficiency and hyperactive behavior.

Huang J, Zhong Z, Wang M, Chen X, Tan Y, Zhang S, He W, He X, Huang G, Lu H, Wu P, Che Y, Yan YL, Postlethwait JH, Chen W, Wang H.

J Neurosci. 2015 Feb 11;35(6):2572-87. doi: 10.1523/JNEUROSCI.2551-14.2015.

3.

ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.

Kollins SH, Adcock RA.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:70-8. doi: 10.1016/j.pnpbp.2014.02.002. Review.

4.

Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD.

Cherkasova MV, Faridi N, Casey KF, O'Driscoll GA, Hechtman L, Joober R, Baker GB, Palmer J, Dagher A, Leyton M, Benkelfat C.

Neuropsychopharmacology. 2014 May;39(6):1498-507. doi: 10.1038/npp.2013.349.

5.

The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease.

Stolp H, Neuhaus A, Sundramoorthi R, Molnár Z.

Front Psychiatry. 2012 Jun 12;3:50. doi: 10.3389/fpsyt.2012.00050.

6.

Behavioural symptoms of attention deficit/hyperactivity disorder in preterm and term children born small and appropriate for gestational age: a longitudinal study.

Heinonen K, Räikkönen K, Pesonen AK, Andersson S, Kajantie E, Eriksson JG, Wolke D, Lano A.

BMC Pediatr. 2010 Dec 15;10:91. doi: 10.1186/1471-2431-10-91.

7.

Evaluating dopamine reward pathway in ADHD: clinical implications.

Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y, Pradhan K, Wong C, Swanson JM.

JAMA. 2009 Sep 9;302(10):1084-91. doi: 10.1001/jama.2009.1308. Erratum in: JAMA. 2009 Oct 7;302(13):1420.

8.

Neuroimaging of response interference in twins concordant or discordant for inattention and hyperactivity symptoms.

van 't Ent D, van Beijsterveldt CE, Derks EM, Hudziak JJ, Veltman DJ, Todd RD, Boomsma DI, De Geus EJ.

Neuroscience. 2009 Nov 24;164(1):16-29. doi: 10.1016/j.neuroscience.2009.01.056.

9.

A structural MRI study in monozygotic twins concordant or discordant for attention/hyperactivity problems: evidence for genetic and environmental heterogeneity in the developing brain.

van 't Ent D, Lehn H, Derks EM, Hudziak JJ, Van Strien NM, Veltman DJ, De Geus EJ, Todd RD, Boomsma DI.

Neuroimage. 2007 Apr 15;35(3):1004-20.

10.

Supplemental Content

Support Center